Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT02526212
PHASE3

Buprenorphine Group Medical Visits in Primary Care

Sponsor: Montefiore Medical Center

View on ClinicalTrials.gov

Summary

The primary goal of this research is to improve the effectiveness of buprenorphine maintenance treatment (BMT) within primary care. Investigators propose that providing BMT as part of a group medical visit (instead of an individual visit) will improve treatment outcomes for patients with persistent opioid abuse, because members become accountable to the group, are exposed to beneficial habits of others (i.e. positive deviance), and can receive efficacious behavioral interventions concomitantly with medical management

Official title: Buprenorphine Group Medical Visits for Drug Users at Risk for HIV

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

18

Start Date

2017-01-01

Completion Date

2019-05

Last Updated

2026-06-22

Healthy Volunteers

No

Interventions

BEHAVIORAL

G-BMT

The G-BMT intervention will include weekly group visits (for 8 weeks) where 5-10 patients simultaneously receive care from a multidisciplinary team of a generalist physician and a behavioral specialist. Group visits will last 90 minutes and include: BMT education, instruction on self-management skills, peer support, and individual medical management.

BEHAVIORAL

Treatment as usual

Primary care physicians who prescribe buprenorphine will be trained to follow a protocol of BMT intensification, which includes increased visit frequency, referral for mental health counseling, and referral to addiction treatment specialist.

DRUG

Buprenorphine

All participants will continue to receive maintenance treatment with buprenorphine-naloxone

Locations (1)

Comprehensive Health Care Center

The Bronx, New York, United States